Sponsor

National Jewish Health

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name National Jewish Health appears in 56 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials56
Recruiting shown4
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

56 shown
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyNCT02947945 · lead sponsor · 2017-09-12
RECRUITING
MOBoxy: MoblO2 to Maintain OxygenationNCT07222592 · lead sponsor · 2025-12-01
NOT_YET_RECRUITING
Nasal Inflammation Following Endotoxin Challenge in Patients With AsthmaNCT06270576 · lead sponsor · 2024-04-01
NOT_YET_RECRUITING
Measuring Omalizumab Responses Using Real-world Evidence (MORRE) StudyNCT04724278 · lead sponsor · 2021-02-05
UNKNOWN
Creation of Home-based Asthma Real-World Measures With Mobile Health StudyNCT04462224 · lead sponsor · 2021-01-11
UNKNOWN
Skin Barrier Assessment in Pregnancy and at BirthNCT04445298 · lead sponsor · 2020-08-03
UNKNOWN
Use of DNAse in Neutrophilic AsthmaNCT03994380 · lead sponsor · 2020-02-12
COMPLETED
Asthma and Intimate Partner ViolenceNCT04216680 · lead sponsor · 2020-01-02
UNKNOWN
Reverse HFpEF: Ketogenic Reversal of Heart Failure With Preserved Ejection Fraction StudyNCT04942548 · lead sponsor · 2019-07-25
COMPLETED
Genetics and Genomics of Aspirin Exacerbated Respiratory Disease (AERD)NCT04261582 · lead sponsor · 2018-11-06
SUSPENDED
Investigate the Development and Progression of Lung Disease in Rheumatoid Arthritis Over TimeNCT03616158 · lead sponsor · 2018-05-10
UNKNOWN
Interstitial Lung Disease in Early Rheumatoid ArthritisNCT03977415 · lead sponsor · 2018-03-27
UNKNOWN
An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo NationNCT03377647 · lead sponsor · 2017-08-01
ACTIVE_NOT_RECRUITING
Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) StudyNCT03010436 · lead sponsor · 2017-04-15
ACTIVE_NOT_RECRUITING
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant AsthmaNCT02753764 · lead sponsor · 2017-01-01
COMPLETED
The Breathe Well Program for Adults With AsthmaNCT02761837 · lead sponsor · 2016-10-01
COMPLETED
Pneumococcal Post-Vaccination TitersNCT02726347 · lead sponsor · 2016-04-01
UNKNOWN
Colorado Marijuana Users Health CohortNCT02735954 · lead sponsor · 2014-09-01
UNKNOWN
Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionNCT02220634 · lead sponsor · 2014-08-01
TERMINATED
COPDGene/Lung Cancer Center DatabaseNCT02445183 · lead sponsor · 2013-12-01
COMPLETED
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial HypertensionNCT02169752 · lead sponsor · 2012-09-01
TERMINATED
Lung Cancer Screening Study With Low-dose CT Scan and Blood BiomarkerNCT01700257 · lead sponsor · 2012-05-01
COMPLETED
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)NCT01253473 · lead sponsor · 2012-04-01
COMPLETED
Identification of Molecular Biomarkers to Stratify Patients With Refractory AsthmaNCT01589198 · lead sponsor · 2012-01-01
COMPLETED
Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial HypertensionNCT01491646 · lead sponsor · 2010-11-01
COMPLETED
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)NCT01117116 · lead sponsor · 2010-03-01
COMPLETED
Telecommunication Enhanced Asthma ManagementNCT00958932 · lead sponsor · 2009-09-01
COMPLETED
Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE LevelsNCT00851370 · lead sponsor · 2009-01-01
WITHDRAWN
Progression of Airway Obstruction in Childhood AsthmaNCT00873873 · lead sponsor · 2008-09-01
COMPLETED
Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART RegimenNCT00738569 · lead sponsor · 2008-07-01
COMPLETED
Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)NCT00700921 · lead sponsor · 2008-04-01
COMPLETED
Markers of Airway Inflammation in BAL Fluid From Children With AsthmaNCT00838552 · lead sponsor · 2007-10-01
COMPLETED
Examining the Link Between Obesity, Inflammation, and Response to Asthma MedicationsNCT00557180 · lead sponsor · 2007-10-01
COMPLETED
Cell Biology of Steroid Resistant AsthmaNCT00361920 · lead sponsor · 2006-08-01
COMPLETED
The Effect of Obesity on Lung FunctioningNCT00284895 · lead sponsor · 2005-11-01
COMPLETED
Effect of CPAP (Continuous Positive Airway Pressure) on Lung Function in Asthmatics With Sleep ApneaNCT00238069 · lead sponsor · 2004-12-01
COMPLETED
Evaluating Genes in Sputum to Measure Drug Response in COPDNCT00233051 · lead sponsor · 2003-04-01
TERMINATED
The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary DiseaseNCT00238082 · lead sponsor · 1999-11-01
TERMINATED
Study to Improve Deployment Related Asthma by Using L-Citrulline SupplementationNCT05259904 · collaborator · 2023-03-08
RECRUITING
SPIROMICS Study of Early COPD Progression (SOURCE)NCT05033990 · collaborator · 2021-09-08
RECRUITING
Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsNCT03215836 · collaborator · 2017-08-10
RECRUITING
Real World and Genomic Data Based Asthma Insight Through Network AnalysisNCT06623435 · collaborator · 2019-11-07
COMPLETED
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)NCT03583099 · collaborator · 2018-10-12
COMPLETED
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)NCT03581227 · collaborator · 2018-10-12
COMPLETED
CompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHNCT03726398 · collaborator · 2018-09-01
WITHDRAWN
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)NCT03653611 · collaborator · 2018-07-30
COMPLETED
Steroid Resistance During COPD Exacerbations With Respiratory FailureNCT03680495 · collaborator · 2017-07-21
UNKNOWN
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and CaregiversNCT02098369 · collaborator · 2015-04-01
COMPLETED
PATient Navigator to rEduce ReadmissionsNCT02114515 · collaborator · 2014-07-01
COMPLETED
WTC Chest CT Imaging ArchiveNCT03295279 · collaborator · 2012-09-01
ENROLLING_BY_INVITATION
Study of COPD Subgroups and BiomarkersNCT01969344 · collaborator · 2010-11-01
ACTIVE_NOT_RECRUITING
A Prospective Observational Study of Biopredictors of Bronchial Thermoplasty Response in Patients With Severe Refractory Asthma (BTR Study)NCT01185275 · collaborator · 2010-08-01
COMPLETED
Airway Epithelium Gene Expression: AEGIS IDENCT00746759 · collaborator · 2010-02-01
COMPLETED
Heart Rate Variability Biofeedback: It's Role in Asthma TherapeuticsNCT02766374 · collaborator · 2009-12-01
COMPLETED
MethaCholine Bronchoprovocation Study (MeCIS)NCT00705341 · collaborator · 2009-01-01
COMPLETED
COPD Research RegistryNCT01785706 · collaborator · 2007-03-01
COMPLETED

Drugs studied in this sponsor's trials

10 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing National Jewish Health as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
prednisone2
ambrisentan1
benralizumab1
budesonide1
fluticasone1
lovastatin1
methylprednisolone1
raltegravir1
prednisone RxCUI 8640 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials ambrisentan RxCUI 358274 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial benralizumab RxCUI 1989100 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial budesonide RxCUI 19831 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fluticasone RxCUI 41126 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial lovastatin RxCUI 6472 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial methylprednisolone RxCUI 6902 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial raltegravir RxCUI 719872 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial reslizumab RxCUI 1746889 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial salmeterol xinafoate RxCUI 72616 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor38
collaborator18
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.